Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves’ orbitopathy
- 23 May 2012
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 26 (3), 291-302
- https://doi.org/10.1016/j.beem.2011.10.002
Abstract
No abstract availableKeywords
This publication has 105 references indexed in Scilit:
- Increased Expression of TSH Receptor by Fibrocytes in Thyroid-Associated Ophthalmopathy Leads to Chemokine ProductionJournal of Clinical Endocrinology & Metabolism, 2012
- Fibroblasts Expressing the Thyrotropin Receptor Overarch Thyroid and Orbit in Graves' DiseaseJournal of Clinical Endocrinology & Metabolism, 2011
- Significance of Prediagnostic Thyroid Antibodies in Women with Autoimmune Thyroid DiseaseJournal of Clinical Endocrinology & Metabolism, 2011
- Divergent Sp1 Protein Levels May Underlie Differential Expression of UDP-Glucose Dehydrogenase by FibroblastsPublished by Elsevier BV ,2011
- Insulin-Like Growth Factor-I Regulation of Immune Function: A Potential Therapeutic Target in Autoimmune Diseases?Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2010
- Increased Generation of Fibrocytes in Thyroid-Associated OphthalmopathyJournal of Clinical Endocrinology & Metabolism, 2010
- Thyrotropin Receptor Activation Increases Hyaluronan Production in Preadipocyte FibroblastsJournal of Biological Chemistry, 2009
- Divergent Frequencies of IGF-I Receptor-Expressing Blood Lymphocytes in Monozygotic Twin Pairs Discordant for Graves’ Disease: Evidence for a Phenotypic Signature Ascribable to Nongenetic FactorsJournal of Clinical Endocrinology & Metabolism, 2009
- Unique Attributes of Orbital Fibroblasts and Global Alterations in IGF-1 Receptor Signaling Could Explain Thyroid-Associated OphthalmopathyThyroid®, 2008
- Biological Effects of Thyrotropin Receptor Activation on Human Orbital PreadipocytesPublished by Association for Research in Vision and Ophthalmology (ARVO) ,2006